Generics..Are they what they’re cracked up to be?
Monday, May 19th, 2008In the first half of 2007, many patients switched from Wellbutrin XL300 to the newly available generic “equivalent,” Teva’s Budeprion XL300.
Following the switch, 85 people reported immediate undesirable outcomes, including a loss of the antidepressant effect. More than half of the patients switched back to Wellbutrin and reported improvement. Today, the NIMH confirmed these claims and the FDA will now reexamine the bioequivalence of the two drugs.
As we all know, the lack of efficacy in the generic could be much higher than reported, since many bipolar patients and their doctors likely attributed the slip in wellness to the natural cycling of the disease or a developed resistance to the drugs effects.
Just goes to show, we have to log our moods and log our meds in order to have reliable information to share with docs. Sometimes coincidence is not!
If you experienced problems after switching to a generic, talk to your doc and insurance carrier about switching back, and cite this study.
Click HERE to view the FDA report.
